The chemotactic receptor for human C5a anaphylatoxin.

Cloning of the Human C5a Anaphylatoxin Receptor, and More.

Construction and expression of a novel recombinant anaphylatoxin, C5a-N19, as a probe for the human C5a receptor.

Human C5a anaphylatoxin: gene cloning and expression in Escherichia coli.

Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.

Anaphylatoxin C5a modulates hepatic stellate cell migration.

Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.

C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury.

Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice.

Human C5a-related synthetic peptides as neutrophil chemotactic factors.

Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice.

C5a activity.

A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a.

Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Partial characterization of in vivo chemotactic activity: comparison to human C5a.

Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.

Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.

Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.

Relationship of chemotactic receptors for formyl peptide and C5a to CR1, CR3, and Fc receptors on human neutrophils.

C5a and formyl peptide receptor regulation on human monocytes.

Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury.

Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex.

Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.

C4a: the third anaphylatoxin of the human complement system.

Suggest Documents

Cloning of the Human C5a Anaphylatoxin Receptor, and More.

Construction and expression of a novel recombinant anaphylatoxin, C5a-N19, as a probe for the human C5a receptor.

Human C5a anaphylatoxin: gene cloning and expression in Escherichia coli.

Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.

Anaphylatoxin C5a modulates hepatic stellate cell migration.

Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.

C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury.

Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice.

Human C5a-related synthetic peptides as neutrophil chemotactic factors.

Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice.

C5a activity.

A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a.

Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Partial characterization of in vivo chemotactic activity: comparison to human C5a.

Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.

Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.

Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.

Relationship of chemotactic receptors for formyl peptide and C5a to CR1, CR3, and Fc receptors on human neutrophils.

C5a and formyl peptide receptor regulation on human monocytes.

Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury.

Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex.

Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.

C4a: the third anaphylatoxin of the human complement system.

The chemotactic receptor for human C5a anaphylatoxin.

Recommend Documents

Follow Us